Highlights from 11th Breast-Gynecological and Immunooncology International Cancer Conference (BGICC), 17-18 January 2019, Egypt

Hesham El-Ghazaly; Nermean Bahie-Eldin; Adel Aref

doi:10.3332/ecancer.2019.926

Highlights from 11th Breast-Gynecological and Immunooncology International Cancer Conference (BGICC), 17-18 January 2019, Egypt

Ecancermedicalscience. 2019 May 1:13:926. doi: 10.3332/ecancer.2019.926. eCollection 2019.

Authors

Hesham El-Ghazaly^{1

2}, Nermean Bahie-Eldin^{1

2}, Adel Aref^{1

3}

Affiliations

¹ Breast and Gynecological International Cancer Society (BGICS), Cairo 11220, Egypt.
² Clinical Oncology Department, Ain Shams University, Cairo 11566, Egypt.
³ School of Medicine, University of Adelaide, Adelaide SA 5005, Australia.

Abstract

During the 11th Breast-Gynecological and Immunooncology International Cancer Conference (BGICC), which was held on 17 and 18 January 2019, in Cairo, Egypt, around 100 international, regional and national experts from every continent presented the latest updates in breast cancer, gynaecological cancers and immunotherapy in oncology. Through this report, we highlight the important data and consensus issues that were discussed during the conference.

Keywords: BGICC; BGICS; breast cancer; gynaecological cancer; immunotherapy.